Patents by Inventor Gary Pusillo

Gary Pusillo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230114590
    Abstract: Novel products formulated for use as nutritional supplements are designed to enhance oral health and immune function in mammals. An exemplary composition can be customized by adding nutritional or therapeutic ingredients according to a health condition or medical requirement. Oral formulations are described which can be used as dietary supplements on a daily basis to effectively prevent plaque formation in the oral cavity in addition to providing immune protection mediated by enhancing saliva secretions.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Inventor: GARY PUSILLO
  • Publication number: 20220000963
    Abstract: Novel nutritional compositions supporting health and growth in mature and young animals are disclosed. The compositions are useful for the feeding of animals, particularly those used for food, performance animals, such as horses, and companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective not only in supporting the growth and health but also in supporting and stimulating the immune system, and in mitigating undesirable infections. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and combined with and of a number health supporting ingredients, especially fatty acids which in combination with the peptides provide significantly enhanced health benefits.
    Type: Application
    Filed: September 15, 2021
    Publication date: January 6, 2022
    Inventor: GARY PUSILLO
  • Patent number: 11123381
    Abstract: Novel nutritional compositions and methods for their manufacture, administration and use are disclosed. The nutritional compositions of the present invention are useful for the feeding of immature mammals, particularly those used for food, and/or performance animals, such as horses, and for companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective in supporting the growth and health of the immature mammal, in supporting and stimulating its immune system, and in mitigating undesirable infections and other. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and utilized as therapeutic agents.
    Type: Grant
    Filed: September 14, 2020
    Date of Patent: September 21, 2021
    Assignee: INTEQ, LLC
    Inventor: Gary Pusillo
  • Publication number: 20200405780
    Abstract: Novel nutritional compositions and methods for their manufacture, administration and use are disclosed. The nutritional compositions of the present invention are useful for the feeding of immature mammals, particularly those used for food, and/or performance animals, such as horses, and for companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective in supporting the growth and health of the immature mammal, in supporting and stimulating its immune system, and in mitigating undesirable infections and other. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and utilized as therapeutic agents.
    Type: Application
    Filed: September 14, 2020
    Publication date: December 31, 2020
    Inventor: GARY PUSILLO
  • Patent number: 10772344
    Abstract: Novel nutritional compositions and methods for their manufacture, administration and use are disclosed. The nutritional compositions of the present invention are useful for the feeding of immature mammals, particularly those used for food, and/or performance animals, such as horses, and for companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective in supporting the growth and health of the immature mammal, in supporting and stimulating its immune system, and in mitigating undesirable infections and other. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and utilized as therapeutic agents.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: September 15, 2020
    Assignee: INTEQ, LLC
    Inventor: Gary Pusillo
  • Publication number: 20190313667
    Abstract: Novel nutritional compositions and methods for their manufacture, administration and use are disclosed. The nutritional compositions of the present invention are useful for the feeding of immature mammals, particularly those used for food, and/or performance animals, such as horses, and for companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective in supporting the growth and health of the immature mammal, in supporting and stimulating its immune system, and in mitigating undesirable infections and other. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and utilized as therapeutic agents.
    Type: Application
    Filed: December 28, 2018
    Publication date: October 17, 2019
    Inventor: GARY PUSILLO
  • Publication number: 20080166436
    Abstract: Otitis externa is a condition of the outer ear canal in mammalian animals, especially dogs and cats, marked by inflammation and infection of tissue, buildup of ear wax, and draining of ear exudate. Symptoms of infection are, among others, excessive cerumen, alopecia in the ear flap, crusts, and ear pruritis. Typical causes of otitis externa are fungi, bacteria, and mites. A medicating mixture in accordance with the invention, comprising cold-pressed citrus oil, deionized water, and, optionally, hydrolysates of milk proteins, when applied topically to an infected ear canal can produce significant reduction in symptoms. In a clinical study, 95% of an infected population of dogs were normalized without other or further treatment.
    Type: Application
    Filed: January 10, 2007
    Publication date: July 10, 2008
    Applicant: Apperon Inc.
    Inventor: Gary Pusillo